Pediatric Flu Vaccine – 2025-2026

The Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) requires the award of one or more indefinite quantity, indefinite delivery contracts for the purchase of the following pediatric vaccines and estimated quantities manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration:

Item Descriptions & Quantities: Pediatric Influenza Vaccine (age 0 through 18 years)

Min. Order Size: 100 Doses

Fed. Excise Tax: $0.75 per dose

Maximum: 30,000,000 doses

Minimum: 100 doses

Provide age indication and NDC for any vaccines proposed.

Proposed Quantity and Presentation: Offerors may propose any number of vaccines or presentations of influenza vaccine (IV).

The vaccines awarded under the resulting contracts will be purchased for and by NCIRD's immunization awardees to support pediatric immunization programs as provided under Section 317(j) of the Public Health Service Act and Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA '93).

The Contractor shall be required to deliver vaccines F.O.B. Destination, as directed by delivery orders to the CDC centralized distribution locations currently in Olive Branch, MS; Aurora, CO and Clermont, KY. Vaccine stockpile order(s) shall be delivered to another single location to be determined by CDC.

The period of performance shall be from the date of award through February 28, 2026. This acquisition will be conducted in accordance with FAR Part 12, Acquisition of Commercial Items, in conjunction with FAR Part 15. The solicitation and any amendments issued will be posted on www.sam.gov if/when issued. No hard copies of the solicitation and amendments will be mailed. Please note funds are not currently available for the award. This solicitation is subject of funds availability during FY 2025. Any questions regarding this notice shall be submitted in writing ONLY to Matheu Wilson (zlb4@cdc.gov) and David Dombeck at vwj8@cdc.gov. Telephone inquiries will not be honored.